Plus   Neg

Regeneron Pharmaceuticals Q4 adjusted earnings Beat Estimates

Regeneron Pharmaceuticals (REGN) announced a profit for its fourth quarter that increased from last year.

The company's profit came in at $820.4 million, or $7.15 per share. This compares with $173.5 million, or $1.50 per share, in last year's fourth quarter.

Excluding items, Regeneron Pharmaceuticals reported adjusted earnings of $785.7 million or $6.84 per share for the period.

Analysts had expected the company to earn $5.78 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 22.2% to $1.93 billion from $1.58 billion last year.

Regeneron Pharmaceuticals earnings at a glance:

-Earnings (Q4): $785.7 Mln. vs. $607.2 Mln. last year.
-EPS (Q4): $6.84 vs. $5.23 last year.
-Analysts Estimate: $5.78
-Revenue (Q4): $1.93 Bln vs. $1.58 Bln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT